Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SpectrumAi

Explore full profile

Modernizing and democratizing access to high-quality autism treatment

Los Angeles, United StatesFounded 2021Health Tech & Medtech
Valuation $100–250M Last recorded · 2023
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SpectrumAi and the history behind them.

About SpectrumAi

SpectrumAi is a digital health company that has developed a platform to improve the quality and effectiveness of Applied Behavior Analysis (ABA) therapy for children with autism.

The company provides a suite of tools for clinicians, including data collection and management systems, to help them deliver more personalized and effective care. By leveraging data analytics and artificial intelligence, SpectrumAi offers insights into treatment progress and outcomes. This allows for better decision-making and a more standardized approach to therapy, addressing the need for more consistent quality in the autism care industry.

SpectrumAi operates on a B2B model, primarily serving ABA providers and healthcare payers. For providers, the platform streamlines workflows and enhances therapy delivery. For payers, it offers data and analytics to measure the quality and value of the care being provided, which can help in making more informed reimbursement decisions. The company is backed by venture capital funding, indicating a growth-oriented strategy within the healthcare technology sector.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2021
Headquarters
Los Angeles, United States
Employees
12
Open positions
None listed
Dealroom signal
31.0/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Core AI, Hard Tech, AI Applications
Technology
Artificial Intelligence
Business model
SaaS
Client focus
b2b
Links
WebsiteLinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Aug 2025 $0 — Central Reach ↗
SERIES A✓Equity / VC Mar 2023 $20M $80M F-Prime · Cobalt Ventures · Frist Cressey Ventures · CVS Health Ventures ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

SpectrumAi website traffic

Latest recorded traffic for SpectrumAi is 2.2K monthly website visits, up 168.3% over the last three months. SpectrumAi's team declined 14.3% over the past year.

Latest monthly visits2.2K 3-month web change+168.3% 1-year team growth-14.3%
Monthly website visitsDec 2022–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
OculusmaximaOculus Maxima: AI-driven telemedicine for eye exams Nottingham, United Kingdom Operational — $92K —
IMU BiosciencesAI-powered platform decoding the immune system London, United Kingdom Operational
AirBiometricsHelps to regain sovereignty over well-being Castellón de la Plana, Spain Operational
PicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning Oxford, United Kingdom Operational
Microplate DxRapid diagnostic platform for antibiotic susceptibility testing Glasgow, United Kingdom Operational
UnforgedDigital mental wellness for Gen Z-centric organisations London, United Kingdom Operational
ElevateMeAt-home blood tests with personalized AI-driven health insights London, United Kingdom Operational
CliniNoteEnables data-driven medicine Warsaw, Poland Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Frist Cressey Ventures
  • F-Prime
  • Autism Impact Fund

Series A2 investors entered at this stage

  • CVS Health Ventures
  • Cobalt Ventures

Other known investors3 additional known investors

  • Central Reach
  • Nucleate
  • Valeo Ventures

Talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Los Angeles HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SpectrumAi on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SpectrumAi’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.